MR imaging-guided focused ultrasound surgery of breast cancer: Correlation of dynamic contrast-enhanced MRI with histopathologic findings

Breast Cancer Research and Treatment

Volumn 82, Issue 2, 2003, Pages 93-101

  Gianfelice, David ^a   Khiat, Abdesslem ^a   Amara, Mourad ^a   Belblidia, Assia ^a   Boulanger, Yvan ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Breast neoplasms; Dynamic contrast enhanced magnetic resonance imaging; Focused ultrasound surgery; Histopathology; Residual tumor; Signal enhancement

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; RESIDUAL VOLUME; ULTRASOUND;

AGED; ALGORITHMS; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 0345688804     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000003956.11376.5b     Document Type: Article

References (29)

1. Jolesz FA, Hynynen K: Magnetic resonance image-guided focused ultrasound surgery. Cancer J 8(Suppl 1): S100-S112, 2002
2. Moonen CTW, Quesson B, Salomir R, Vimeux FC, de Zwart JA, van Vaals JJ, Grenier N, Palussière J: Thermal therapies in interventional MR imaging. Focused ultrasound. Neuroimaging Clin N Am 11: 737-747, 2001
3. Bohris C, Schreiber WG, Jenne J, Simiantonakis I, Rastert R, Zabel HJ, Huber P, Bader R, Brix G: Quantitative MR temperature monitoring of high-intensity focused ultrasound therapy. Magn Reson Imaging 17: 603-610, 1999
4. Padhani AR, Husband JE: Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 56: 607-620, 2001
5. Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Erning LJ, Hendriks JH, Holland R, Ruys SH: MRI characterization of suspicious breast lesions with a gadolinium-enhanced Turbo FLASH subtraction technique. Radiology 193: 777-781, 1994
6. 1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232, 1999
7. Hulka CA, Edmister WB, Smith BL, Tan L, Sgroi DC, Campbell T, Kopans DB, Weisskoff RM: Dynamic echoplanar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 205: 837-842, 1997
8. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH: Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211: 101-110, 1999
9. Tsuboi N, Ogawa Y, Inomata T, Yoshida D, Yoshida S, Moriki T, Kumon M: Changes in the findings of dynamic MRI by pre-operative CAF chemotherapy for patients with breast cancer of stage II and III: pathologic correlation. Oncol Rep 6: 727-732, 1999
10. Trecate G, Ceglia E, Stabile F, Tesoro-Tess JD, Mariani G, Zambetti M, Musumeci R: Locally advanced breast cancer treated with primary chemotherapy: comparison between magnetic resonance imaging and pathologic evaluation of residual disease. Tumori 85: 220-225, 1999
11. Dao TH, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A: Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187: 751-755, 1993
12. Gilles R, Guinebretiere JM, Shapeero LG, Lesnik A, Contesso G, Sarrazin D, Masselot J, Vanel D: Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 188: 473-478, 1993
13. Hayes C, Padhani AR, Leach MO: Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15: 154-163, 2002
14. Reddick WE, Taylor JS, Fletcher BD: Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma. J Magn Reson Imaging 10: 277-285, 1999
15. Barentsz JO, Berger-Hartog O, Witjes JA, Hulsbergen-van der Kaa C, Oosterho GO, VanderLaak JA, Kondacki H, Ruijs SH: Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 207: 791-797, 1998
16. Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky JI, Magnotta VA, Berbaum KS, Zhen W, Paulino AC, Oberley LW, Sood AK, Buatti JM: Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 12: 1027-1033, 2000
17. Padhani AR, MacVicar DA, Gapinski CJ, Dearnaley DP, Parker GJ, Suckling J, Leach MO, Husband JE: Effects of androgen deprivation treatment on prostate morphology and vascular permeability evaluated by magnetic resonance imaging. Radiology 218: 365-374, 2001
18. de Vries A, Griebel G, Kremser C, Judmaier W, Gneiting T, Debbage P, Kremser T, Pfeiffer K-P, Buchberger W, Lukas P: Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 217: 385-391, 2000
19. Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y: MR imaging-guided focused ultrasound surgery of breast cancer: histopathologic assessment of efficacy - initial experience. Radiology 227: 849-855, 2003
20. Mussurakis S, Buckley DL, Coady AM, Turnbull LW, Horsman A: Observer variability in the interpretation of contrast enhanced MR1 of the breast. Br J Radiol 69: 1009-1016, 1996
21. Furman-Haran E, Margalit R, Grobgeld D, Degani H: Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF-7 human breast tumors. Proc Natl Acad Sci USA 93: 6247-6251, 1996
22. Furuta A, Ishibashi T, Takahashi S, Yamada S, Ohuchi N, Amano G, Goto K, Watanabe M: Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis. Nippon Igaku Hoshasen Gakkai Zasshi 59: 682-688, 1999
23. Stomper PC, Winston JS, Herman S, Klippenstein DL, Arredondo MA, Blumenson LE: Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 45: 39-46, 1997
24. Makris A, Powles TJ, Kakolyris S, Dowsett M, Ashley SE, Harris AL: Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma. Cancer 85: 1996-2000, 1999
25. Lindner DJ, Borden EC: Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis. Int J Cancer 71: 456-461, 1997
26. Drew PJ, Kerin MJ, Mahapatra T, Malone C, Monson JR, Turnbull LW, Fox JN: Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 27: 617-620, 2001
27. Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM: MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with X-ray mammography and palpation. J Magn Reson Imaging 13: 868-875, 2001
28. Furman-Haran E, Grobgeld D, Margalit R, Degani H: Response of MCF-7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method. Clin Cancer Res 4: 2299-2304, 1998
29. Dobson MJ, Carrington BM, Collins CD, Ryder WD, Read G, Hutchinson CE, Hawnaur JM: The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol 56: 94-98, 2001